Last €16.03 EUR
Change Today -0.53 / -3.20%
Volume 0.0
AB3A On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:09 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David Tyronne Howton

Senior Vice President, General Counsel and Corporate Secretary, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

42$2,640,699
As of Fiscal Year 2013

Background*

Mr. David Tyronne Howton, also known as Ty, has been Senior Vice President and General Counsel of Sarepta Therapeutics, Inc. since November 05, 2012. Mr. Howton served as Senior Vice President and a Member of the Executive Team at Vertex Pharmaceuticals and also served as its Chief Legal Officer its since 2011. He participated in the general management of Vertex Pharmaceuticals and oversaw all aspects of the Vertex global legal and compliance departments. Mr. Howton ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 857-242-3700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Yale University
JD
Northwestern University School of Law

Other Affiliations*

Annual Compensation*

Salary$376,913
Total Annual Compensation$376,913

Stock Options*

All Other Compensation$12,318
Exercisable Options40,625
Unexercisable Options154,375
Total Number of Options240,000

Total Compensation*

Total Annual Cash Compensation$554,409
Total Short Term Compensation$376,913
Other Long Term Compensation$12,318
Total Calculated Compensation$2,640,699
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AB3A:GR €16.03 EUR -0.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
William A. Carter M.D.Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee
Hemispherx Biopharma, Inc.
$1.0M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.